In a blending of online and live learning, this course provides an overview of the process and issues common to all new chemical entity (NCE) development projects, from the research and development stages through product launch and post-marketing safety. The course focuses on the decisions that need to be made throughout the therapeutic development process and the criteria influencing these decisions. The faculty for this flagship course are selected as experts in their field. The online component is PERI’s Decision Points in Drug Development.
Course Webcast Available
Interested in the course but unable to attend in person? This course is available to stream
live online! Register for the entire course webcast for only $795/per person.
Benefits of Attendance
Continuing Education Credit
Pharmaceutical Education & Research Institute, Inc. (PERI) is pleased to make continuing education credit available to you for attendance at this program. To receive credit, you must attend the entire program and submit the Continuing Education Application form directly to a PERI on-site coordinator.
Pharmaceutical Education & Research Institute, Inc. (PERI) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number is 0708-0000-15-006-L03-P. 1.4 continuing education units (CEUs) are available for this program. Initial Release Date: 11/05/2015. This is a knowledge based CPE Activity.
PERI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PERI, Inc. designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Q: Which studies are completed during the preclinical Learning Phase of drug development?
A: In vitro studies, in vivo studies and blood sample collection for pharmacokinetic data.
Did you know the right answer? Learn more about the preclinical development process during this two-day course!
Date: November 5-6, 2015
Location: Hyatt Arlington Hotel
Arlington, VA 22209
Course Rate: $1595
Early Bird Rate: $1395
Early Bird Deadline: 09/21/15
Please have your credit card ready in order to complete registration.
Hotel Accommodations: Save 10% off current rates at the Hyatt Arlington when you make reservations by phone at 703-908-4661.
Request a Proposal
Interested in bringing this course to your company? Request a proposal and a PERI team member will be in touch about hosting this course as a Corporate Education program.
Carolyn D Finkle, MSc
Senior Vice President
InVentiv Health Clinical
1 “This provided an overview of the drug development process which enables me to understand the tasks my colleagues undertake.”
2 “Love the workshops! Excellent activities and follow-up discussions. I learned that it is not easy to manage a portfolio because of all the elements you must consider.”